CHU Grenoble Alpes
La Tronche, 38043, France
NCT Number: NCT03736239
Evaluate the evolution of diaphragmatic muscle effort in cardiogenic shock in ECMO patient with ultrasounds during the first weaning attempt in intensive care patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
La Tronche, 38043, France
Diaphragmatic atrophy and diaphragmatic dysfunction are described in human resuscitation under mechanical ventilation, but this diaphragmatic function has not been studied in patients with cardiogenic shock and also under cardiac assistance by extracorporeal circulation called ECLS (Extra -corporeal Life support). Diaphragmatic dysfunction in intensive care has been described during prolonged stay in intensive care and early sepsis. It is associated with dyspnea and delayed weaning from mechanical ventilation. The atrophy of the diaphragm muscle is related to both loss of function and also loss of muscle performance.
Decreases in heart muscle and diaphragm performance may require both cardiac and respiratory assistance. Cardiac and respiratory dysfunctions can complicate the weaning of the respiratory assistance and also extracorporeal circulatory support supports. These two supports, respiratory and circulatory assistance, allow the purification of CO2 and respiratory assistance is known to influence the diaphragmatic function. The role of the muscular pump function in the withdrawal process of the ECLS, remains largely unknown. The aim of our study is to give a description of the physiology of the diaphragm in case of cardiogenic shock: we want to evaluate the force of the diaphragm according to the ventilation under ECLS. No studies have yet evaluated the influence of ECLS as a CO2 purification system on the performance of the diaphragm muscle.
Ultrasound is used in the patient's bed in daily practice to measure cardiac function, vessel study and diaphragm muscle. This method is reproducible and non-invasive. It can be hypothesized that there is a muscular involvement of the diaphragm under extracorporeal membrane oxygenation (ECMO) measurable by ultrasound method. Our main hypothesis is that the diaphragm force evolves according to the cleaning of the CO2 by the ECLS during the weaning of this one.
This is a Monocentric Prospective Observational Descriptive study. The objective of this study is to evaluate prospectively and consecutively the evolution of diaphragmatic muscle stress in cardiogenic shock with ultrasounds during the first ECMO weaning in intensive care patients.
When cardiogenic shock occurs, during the first ECLS weaning, we also will evaluate prospectively :
And we also will evaluate the impact of the diaphragmatic function on the patient's future:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at 15 min
The performance of the diaphragm muscle will be evaluated by ultrasonography (the thickening fraction of the diaphragm) during the weaning of the ECMO at different weaning level : after 15 minutes (Baseline, 4 l/min, 2 l / min, 1 l / min). Wash out of 10 min between each measurement. The parameters of the assisted ventilation will be standardized according to the practices of the service and recommendations.
Time frame: at 15 min
The thickness of the muscle will be measured when weaning the ECMO at the same scanning levels as before (mm).
Time frame: at 15 min
The function of the muscle will be measured when weaning the ECMO at the same scanning levels as before (%).
Time frame: previous exposure before inclusion
Risk factors will be collected to estimate the impact on the 3 indicators of the diaphragm function (performance, thickness and function).
Time frame: at 60 days
Rate of weaning failure with mechanical ventilation will be collected
Time frame: at 60 days
Rate of weaning failure with ECLS will be collected
Time frame: at 60 days
Rate of mortality in intensive care will be collected.
Time frame: at 60 days
Length of stay in intensive care will be collected.
Association Pro-arte
Other
Acronym: DIAG-ECMO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04886180
Cardiogenic Shock, Cardiovascular Diseases
Dijon, France
View Trial DetailsNCT03773822
Adrenal Gland Diseases, Adrenal Insufficiency
Boulogne-Billancourt, France
View Trial DetailsNCT06487091
Cardiac Arrest, Cardiogenic Shock
Milan, Italy
View Trial DetailsNCT04934566
Cardiogenic Shock, Cardiovascular Diseases
Lille, NORD, France
View Trial Details